Bioventus BVS
$9.88 −$0.07 (-0.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.88 0.00%
Open$9.85
Prev close$9.95
Day range$9.81 – $10.17
Volume612.4K
Market cap$676.53M
P/E (TTM)12.2
Dividend yield–
BVS Stock News
Headlines matching Bioventus or the BVS ticker, most recent first.
- CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 Positive
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $18 Positive
- Earnings Flash (BVS) Bioventus Inc. Posts Q2 Adjusted EPS $0.22 per Share, Vs. FactSet Est of $0.22
- J.P. Morgan Keeps Their Hold Rating on Bravura Solutions Limited (BVS)
- CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $19
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Atai Beckley N.V. (ATAI), Bioventus (BVS) and Crinetics Pharmaceuticals (CRNX)
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $14
- Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $14 Positive
- CJS Securities Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $14
- Barrington Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $13
- Barrington Maintains Bioventus(BVS.US) With Buy Rating, Cuts Target Price to $16 Negative
- CCORF Initiates Bioventus(BVS.US) With Buy Rating, Announces Target Price $18
No comments yet — be the first to weigh in on BVS.
Sign in to join the discussion.